Does rituximab influence the prognostic effect of germinal centre phenotype in diffuse large B-cell lymphoma?

被引：1
|
作者：
Nyman, Heidi
Karjalainen-Lindsberg, Marja-Liisa
Taskinen, Minna
Berglund, Manias
Adde, Magdalena
Amini, Rose-Marie
Blomqvist, Carl
Enblad, Gunilla
Leppa, Sirpa
机构：
[1] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland
[2] Univ Helsinki, Biomed Helsinski, Mol Canc Biol Res Program, Helsinki, Finland
[3] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland
[4] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[5] Univ Uppsala, Univ Uppsala Hosp, Dept Genet & Pathol, Uppsala, Sweden
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2743.2743
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2743
引用
收藏
页码：776A / 776A
页数：1
相关论文
共 50 条
  • [41] LMO2 Expression and the Hans Algorithm in Predicting Germinal Center Phenotype and Survival in Diffuse Large B-Cell Lymphoma Treated with Rituximab
    Meyer, P. N.
    Weisenburger, D. D.
    Choi, W. L.
    Smith, L. M.
    Greiner, T. C.
    Aoun, P.
    Delabie, J.
    Braziel, R. M.
    Vose, J. M.
    Lenz, G.
    Staudt, L. M.
    Chan, W. C.
    Fu, K.
    LABORATORY INVESTIGATION, 2009, 89 : 277A - 277A
  • [42] Diffuse large B cell lymphoma: prognostic factors in the rituximab era
    Guevara Arismendy, Natalia Maria
    Jaramillo Arbelaez, Patricia Elena
    Gaviria Jaramillo, Lina Maria
    IATREIA, 2013, 26 (03) : 302 - 312
  • [43] Serum B-cell activating factor (BAFF) in diffuse large B-cell lymphoma: Its prognostic significance in the rituximab era
    Kim, Seok Jin
    Sung, Hwa Jung
    Choi, Chul Won
    Kim, In Sun
    Kim, Byung Soo
    Yoon, Soo-Young
    Won, Jong-Ho
    Kim, Jun Suk
    BLOOD, 2007, 110 (11) : 470A - 471A
  • [44] Use of rituximab in diffuse large B-cell lymphoma in the salvage setting
    Gisselbrecht, Christian
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (05) : 607 - 621
  • [45] Outcomes of Cardiac Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Al-Juhaishi, Taha
    Abu Zeinah, Ghaith
    Al-Kindi, Sadeer
    BLOOD, 2020, 136
  • [46] Mechanism and Treatment of Rituximab Resistance in Diffuse Large B-cell Lymphoma
    Zou, Linqing
    Song, Guoqi
    Gu, Siyu
    Kong, Lingling
    Sun, Shiqi
    Yang, Li
    Cho, William C.
    CURRENT CANCER DRUG TARGETS, 2019, 19 (09) : 681 - 687
  • [47] Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung
    Aviles, Agustin
    Nambo, Maria J.
    Huerta-Guzman, Judith
    Silva, Luis
    Neri, Natividad
    HEMATOLOGY, 2013, 18 (02) : 81 - 84
  • [48] Rituximab in treatment of primary gastric diffuse large B-cell lymphoma
    Zhang, Jian
    Li, Gang
    Yang, Haiyan
    Liu, Xiaojian
    Cao, Junning
    LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2175 - 2181
  • [49] Primary breast diffuse large B-cell lymphoma in the era of rituximab
    Zhang, Na
    Cao, Caineng
    Zhu, Yuan
    Liu, Peng
    Liu, Luying
    Lu, Ke
    Luo, Jialin
    Zhou, Ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6093 - 6097
  • [50] Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma
    Carol S. Portlock
    Current Oncology Reports, 2003, 5 (5) : 357 - 357
12345